Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

12.12
-0.2600-2.10%
Post-market: 12.120.00000.00%16:10 EDT
Volume:69.20K
Turnover:843.13K
Market Cap:2.11B
PE:120.06
High:12.44
Open:12.44
Low:12.08
Close:12.38
52wk High:18.30
52wk Low:9.77
Shares:174.43M
Float Shares:104.00M
Volume Ratio:1.01
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1010
EPS(LYR):2.60
ROE:1.46%
ROA:-1.24%
PB:1.68
PE(LYR):4.66

Loading ...

HUTCHMED's Savolitinib Gains Conditional NMPA Approval for MET-Amplified Gastric Cancer

Stock News
·
Jul 02

Press Release: Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer

Dow Jones
·
Jun 29

HUTCHMED (China) (HCM) Gets a Buy from UBS

TIPRANKS
·
Jun 27

Why Edgewise Therapeutics (EWTX) Is Up 13.3% After Phase 2 EDG-7500 HCM Data Release

Simply Wall St.
·
Jun 26

Hutchmed Says Phase 2 Trial for Investigational Cancer Drug Meets Primary Endpoint

MT Newswires Live
·
Jun 25

Is Paylocity (PCTY) Using Embedded Retirement Plans to Deepen Its HCM Moat?

Simply Wall St.
·
Jun 23

Paychex Named One of America's Most Trustworthy Companies by Newsweek

GlobeNewswire
·
Jun 22

Edgewise Therapeutics Reports Improvements In Heart Drug Trial

Benzinga
·
Jun 17

Edgewise Therapeutics Advances EDG-7500 to Phase 3 Following 'Positive' HCM Data

MT Newswires Live
·
Jun 16

Paychex Recognized as a Top WorkTech Company by TIME

GlobeNewswire
·
Jun 15

Black Titan Reports January 2026 Results and Outlines HCM and Digital Asset Strategies

TIPRANKS
·
Jun 13

Hutchmed Unveils Phase III Data for Sovleplenib in wAIHA at 2026 EHA Congress

Stock News
·
Jun 12

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

GlobeNewswire
·
Jun 03

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

GlobeNewswire
·
Jun 01

Morgan Stanley Reaffirms Their Hold Rating on HUTCHMED (China) (HCM)

TIPRANKS
·
May 30

Hutchmed upgraded to Equal Weight from Underweight at Morgan Stanley

TIPRANKS
·
May 29

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

GlobeNewswire
·
May 28

UBS Reaffirms Their Buy Rating on HUTCHMED (China) (HCM)

TIPRANKS
·
May 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

HUTCHMED Hits Annual Low: When Will the Turning Point Arrive?

Stock News
·
May 22